Y. Motomiya, Y. Kaneko, Y. Motomiya, and Y. Higashimoto, “Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor”, J Clini Nephrol, vol. 8, no. 3, pp. 132–137, Oct. 2024.